A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
<h4>Background</h4>Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public health as demonstrated by its high associated mortality rate (23-90%) and recent emergence in West Africa for the first time. Although a recombinant vesicular stomatitis virus (rVSV)-based v...
Sábháilte in:
Príomhchruthaitheoirí: | Courtney Woolsey (Údar), Robert W Cross (Údar), Krystle N Agans (Údar), Viktoriya Borisevich (Údar), Daniel J Deer (Údar), Joan B Geisbert (Údar), Cheryl Gerardi (Údar), Theresa E Latham (Údar), Karla A Fenton (Údar), Michael A Egan (Údar), John H Eldridge (Údar), Thomas W Geisbert (Údar), Demetrius Matassov (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Public Library of Science (PLoS),
2022-05-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
de réir: Chad E Mire, et al.
Foilsithe / Cruthaithe: (2013) -
Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys.
de réir: Robert W Cross, et al.
Foilsithe / Cruthaithe: (2020) -
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
de réir: Chad E Mire, et al.
Foilsithe / Cruthaithe: (2012) -
Transgenic nonhuman primates for neurodegenerative diseases
de réir: Chan Anthony WS
Foilsithe / Cruthaithe: (2004) -
Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus.
de réir: Sara Garamszegi, et al.
Foilsithe / Cruthaithe: (2014)